These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 23861236)
1. Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes. Salonen KM; Ryhänen S; Härkönen T; Ilonen J; Knip M; Diabetes Metab Res Rev; 2013 Nov; 29(8):646-54. PubMed ID: 23861236 [TBL] [Abstract][Full Text] [Related]
2. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes. Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F; Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749 [TBL] [Abstract][Full Text] [Related]
3. Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes. Andersen MK; Härkönen T; Forsblom C; Groop PH; Knip M; Tuomi T Autoimmunity; 2013 Jun; 46(4):251-8. PubMed ID: 23194113 [TBL] [Abstract][Full Text] [Related]
4. Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease. Fichna M; Rogowicz-Frontczak A; Żurawek M; Fichna P; Gryczyńska M; Zozulińska-Ziółkiewicz D; Ruchała M Endocrine; 2016 Jul; 53(1):249-57. PubMed ID: 26972575 [TBL] [Abstract][Full Text] [Related]
5. Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany. Kordonouri O; Hartmann R; Charpentier N; Knip M; Danne T; Ilonen J Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):245-9. PubMed ID: 20140847 [TBL] [Abstract][Full Text] [Related]
6. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes. Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE; Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668 [TBL] [Abstract][Full Text] [Related]
7. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity. Mikk ML; Pfeiffer S; Kiviniemi M; Laine AP; Lempainen J; Härkönen T; Toppari J; Veijola R; Knip M; Ilonen J; Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719 [TBL] [Abstract][Full Text] [Related]
8. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes. Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176 [TBL] [Abstract][Full Text] [Related]
9. Associations of polymorphisms in non-HLA loci with autoantibodies at the diagnosis of type 1 diabetes: INS and IKZF4 associate with insulin autoantibodies. Lempainen J; Härkönen T; Laine A; Knip M; Ilonen J; Pediatr Diabetes; 2013 Nov; 14(7):490-6. PubMed ID: 23721563 [TBL] [Abstract][Full Text] [Related]
10. Positivity for Zinc Transporter 8 Autoantibodies at Diagnosis Is Subsequently Associated With Reduced β-Cell Function and Higher Exogenous Insulin Requirement in Children and Adolescents With Type 1 Diabetes. Juusola M; Parkkola A; Härkönen T; Siljander H; Ilonen J; Åkerblom HK; Knip M; Diabetes Care; 2016 Jan; 39(1):118-21. PubMed ID: 26519333 [TBL] [Abstract][Full Text] [Related]
11. Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype. Trabucchi A; Faccinetti NI; Guerra LL; Puchulu FM; Frechtel GD; Poskus E; Valdez SN Autoimmunity; 2012 Mar; 45(2):137-42. PubMed ID: 21875382 [TBL] [Abstract][Full Text] [Related]
12. Progression to type 1 diabetes and autoantibody positivity in relation to HLA-risk genotypes in children participating in the ABIS study. Gullstrand C; Wahlberg J; Ilonen J; Vaarala O; Ludvigsson J Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):182-90. PubMed ID: 18331414 [TBL] [Abstract][Full Text] [Related]
13. Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes? Rogowicz-Frontczak A; Zozuliłska-Ziołkiewicz D; Litwinowicz M; Niedźwiecki P; Wyka K; Wierusz-Wysocka B Eur J Endocrinol; 2014 Apr; 170(4):651-8. PubMed ID: 24480135 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes: results from the HUNT study, Norway. Sørgjerd EP; Skorpen F; Kvaløy K; Midthjell K; Grill V Autoimmunity; 2013 Feb; 46(1):74-9. PubMed ID: 23061550 [TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese. Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762 [TBL] [Abstract][Full Text] [Related]
16. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes]. Hermann R; Gombos Z; Gyürüs E; Soltész G Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382 [TBL] [Abstract][Full Text] [Related]
17. Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus. Huang G; Xiang Y; Pan L; Li X; Luo S; Zhou Z Diabetes Metab Res Rev; 2013 Jul; 29(5):363-8. PubMed ID: 23390067 [TBL] [Abstract][Full Text] [Related]
18. Zinc transporter 8 autoantibodies in patients with type 1 diabetes from a multiethnic population and their first degree relatives. Araujo DB; Skärstrand H; Barone B; Dantas JR; Kupfer R; Zajdenverg L; Milech A; Vaziri-Sani F; Oliveira JE; Rodacki M Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):737-43. PubMed ID: 25372583 [TBL] [Abstract][Full Text] [Related]
19. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients. Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I; Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327 [TBL] [Abstract][Full Text] [Related]
20. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study. Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP; Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]